Tedor Pharma, a full-service contract development and manufacturing organization (CDMO), has entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine Ltd.’s triple combination drug product for the short-term treatment of transient insomnia.   Sequential Medicine’s product has demonstrated impressive efficacy in early studies, and the company is on track to commence its next clinical trial by the end of this year with supply from Tedor. The selection of Te...